Terri Lee, Ph.D.

Dr. Terri Lee is responsible for investment identification, due diligence and business development activities at MPM. Currently, she serves as Interim Director of Strategy and Operations at a newly formed, stealth MPM startup company.

Recently awarded her Ph.D. in Biochemistry and Molecular Biology from the University of California, San Francisco, Terri’s thesis focused on the role of actin nucleators in DNA repair pathways. In addition to academic research, Terri worked on identifying commercial opportunities and company formation at the Gladstone Institutes, including taking on an operations role at a therapeutics company in the neurodegenerative space.

Terri received her B.S. in Pharmacology and Microbiology from the University of California, Santa Barbara.